Bicycle Therapeutics plc (FRA:50BA)
5.90
+0.20 (3.51%)
At close: Jan 23, 2026
Bicycle Therapeutics Revenue
Bicycle Therapeutics had revenue of $11.73M USD in the quarter ending September 30, 2025, with 338.49% growth. This brings the company's revenue in the last twelve months to $28.34M, down -23.20% year-over-year. In the year 2024, Bicycle Therapeutics had annual revenue of $35.28M with 30.76% growth.
Revenue (ttm)
$28.34M
Revenue Growth
-23.20%
P/S Ratio
15.52
Revenue / Employee
$92.91K
Employees
305
Market Cap
374.84M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.28M | 8.30M | 30.76% |
| Dec 31, 2023 | 26.98M | 12.51M | 86.52% |
| Dec 31, 2022 | 14.46M | 2.77M | 23.65% |
| Dec 31, 2021 | 11.70M | 1.31M | 12.58% |
| Dec 31, 2020 | 10.39M | -3.41M | -24.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| FRoSTA Aktiengesellschaft | 652.00M |
| SIMONA Aktiengesellschaft | 586.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| centrotherm international AG | 288.81M |
| Novabase S.G.P.S. | 130.35M |
| Wild Bunch AG | 68.86M |
| EUWAX Aktiengesellschaft | 41.42M |
| STINAG Stuttgart Invest AG | 28.92M |